The abundance of activated CD4 memory T cells has been reported to be associated with patient prognosis in multiple solid tumors, such as colorectal cancer, small-cell lung cancer, and hepatocellular carcinoma (Jiang et al., 2021; Liu et al., 2021; Yu and Zhu, 2021). This evidence concerns the gene CD4 and hepatocellular carcinoma.